Tumor necrosis factor alpha and interleukin 6 release induced by antibiotic killing of Pseudomonas aeruginosa and Staphylococcus aureus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 6, 1997, Pages 467-471

  Schneider, C M ^a   Huzly, D ^a   Vetter, C ^a   Von Specht, B U ^a   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; IMIPENEM; INTERLEUKIN 6; MEROPENEM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL CELL WALL; BACTERICIDAL ACTIVITY; CELL SECRETION; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; HUMANS; INTERLEUKIN-6; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030767959     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02471914     Document Type: Article

References (12)

1. Bone RC: The pathogenesis of sepsis. Annals of Internal Medicine 1991, 115: 457-469.
2. Tomasz A: Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics. Reviews of Infectious Diseases 1985, 8, Supplement 3: 260-278.
3. Shenep JL, Barton RP, Morgan KA: Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. Journal of Infectious Diseases 1985, 151: 1012-1018.
4. Arditi M, Kabat W, Yogev R: Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. Journal of Infectious Diseases 1993, 167: 240-244.
5. Katschinski T, Galanos C, Coumbos A, Freudenberg MA: Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infection and Immunity 1992, 60: 1994-2001.
6. Prins JM, van Deventer SJH, Kuijper EJ, Speelmann P: Clinical relevance of antibiotic-induced endotoxin release. Antimicrobial Agents and Chemotherapy 1994, 38: 1211-1218.
7. Prins JM, Kuijper EJ, Mevissen MLCM, Speelmann P, van Deventer SJH: Release of tumor necrosis factor alpha and interleukin-6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration and presence of septic serum. Infection and Immunity 1995, 63: 2236-2242.
8. Jackson JJ, Kropp H: Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases 1992, 165: 1033-1041.
9. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelmann, P: Antibiotic induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. Journal of Infectious Diseases 1995, 172: 886-891.
10. Ahmed A, Kruse J, Haupt M, Chandrasekar P, Carlson R: Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock. Critical Care Medicine 1991, 19: 1520-1525.
11. Mattson E, Rollof J, Verhoef J, Van Dijk H, Fleer A: Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infection and Immunity 1994, 62: 3837-3843.
12. Timmermann CP, Mattson E, Martinez-Martinez L, De Graaf L, Van Strijp JAG, Verbruch HA, Verhoef J, Fleer A: Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infection and Immunity 1993, 61: 4167-4172.